NCT06952517View on ClinicalTrials.gov

Efficacy and Safety of Topical Clascoterone (WINLEVI) Cream 1% in Patients With Facial Acneiform Rosacea

PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 14, 2025

Primary Completion Date

September 1, 2025

Study Completion Date

September 30, 2025

Conditions
Papular-pustular RosaceaPapulopustular Rosacea (PPR)Papulopustular Rosacea
Interventions
DRUG

Clascoterone Cream 1%

Clascoterone 1% cream

Trial Locations (1)

11209

RECRUITING

New York Harbor VA Brooklyn Campus, Brooklyn

Sponsors
All Listed Sponsors
collaborator

Sun Pharmaceutical Industries Limited

INDUSTRY

lead

Narrows Institute for Biomedical Research

OTHER